
Sign up to save your podcasts
Or


Send us Fan Mail
Mel interviews Karina Sergi, MS, MFT Director, Psychedelic Therapy Training; Director, Diversity, Equity & Inclusion and Keith Heinzerling, MD Director, Treatment & Research In Psychedelics (TRIP) Center; Addiction Medicine.
We discuss psychedelic associated therapy, ketamine, DMT, Psilocybin, Hallucinogen persisting perception disorder (HPPD, Ontological shock, Psychnaughts and so much more as we continue our series on mental health treatment options
The Treatment and Research in Psychedelics clinic (TRIP) located at Pacific Neuroscience Institute. Their website:
https://www.pacificneuroscienceinstitute.org/treatment-research-in-psychedelics/
Support the show
By Mel Herbert for FoolyBoo Inc5
1717 ratings
Send us Fan Mail
Mel interviews Karina Sergi, MS, MFT Director, Psychedelic Therapy Training; Director, Diversity, Equity & Inclusion and Keith Heinzerling, MD Director, Treatment & Research In Psychedelics (TRIP) Center; Addiction Medicine.
We discuss psychedelic associated therapy, ketamine, DMT, Psilocybin, Hallucinogen persisting perception disorder (HPPD, Ontological shock, Psychnaughts and so much more as we continue our series on mental health treatment options
The Treatment and Research in Psychedelics clinic (TRIP) located at Pacific Neuroscience Institute. Their website:
https://www.pacificneuroscienceinstitute.org/treatment-research-in-psychedelics/
Support the show

32,100 Listeners

30,666 Listeners

16,220 Listeners

1,866 Listeners

545 Listeners

260 Listeners

2,446 Listeners

269 Listeners

9,532 Listeners

7,995 Listeners

329 Listeners

257 Listeners

278 Listeners

58 Listeners

6 Listeners